Elevated serum anti-Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease.
Ying ChenLi-Ying ZhangYi FangChuan LiDan-Dan XiaGong ZhangYi WenSong-Zhao ZhangLiu HuLu-Yan GuYi LiuJun TianYa-Ping YanXin-Zhen YinZhi-Hua TaoBao-Rong ZhangJia-Li PuPublished in: European journal of neurology (2023)
Our study identified elevated serum ASCA levels and enriched gut Saccharomyces cerevisiae in de novo PD.